Research Article

Evaluation of Healthcare-Associated Infections in Intensive Care Units

Volume: 8 Number: 2 August 31, 2024
EN TR

Evaluation of Healthcare-Associated Infections in Intensive Care Units

Abstract

Aim: The aim of this study was to determine the healthcare-associated infections (HAIs), causative microorganisms and antibiotic resistance profiles in the tertiary intensive care unit of our hospital and, based on the results, to contribute to the rational administration of antibiotics. Material and Method: The study included patients who were followed up in the tertiary intensive care unit between January 2023 and December 2023 and were diagnosed with HAI. Patient data were obtained retrospectively from infection control nurse records and patient files. Results: During the study period, 107 HAI episodes were identified in 99 of 2296 patients. The incidence rate of HAI was 4.7% and the incidence density was 5.2 per thousand. Central line-associated bloodstream infections (43%) were the most common HAI associated with invasive devices. The next most common were ventilator-associated pneumonia (42%) and catheter-associated urinary tract infection (15%). Gram negative bacteria were isolated in 83.2%, fungi in 10.3%, and gram positive bacteria in 6.5% of patients diagnosed with HAI. The most common gram negative bacteria were Acinetobacter baumannii (34.6%) and Pseudomonas aeruginosa (19.6%). A colistin resistance rate of 8.1% was determined for Acinetobacter baumannii. Carbapenem resistance was 91.9% for Acinetobacter baumannii and 76.2% for Pseudomonas aeruginosa. Methicillin resistance was found in 66.7% of Staphylococcus aureus, the most commonly isolated gram positive bacterium. Conclusion: Monitoring HAIs, causative microorganisms and antibiotic resistance rates in intensive care units is of great importance for both infection prevention and the rational use of antibiotics.

Keywords

References

  1. Manoukian S, Stewart S, Graves N, et al. Evaluating the post-discharge cost of healthcare-associated infection in NHS Scotland. J Hosp Infect. 2021;114:51-58.
  2. Centers for Disease Control and Prevention. Healthcare-Associated Infections (HAIs) [Internet]. Available from: https://www.cdc.gov/healthcare-associated-infections/ Accessed: 05.06.2024
  3. Choudhuri AH, Chakravarty M, Uppal R. Epidemiology and characteristics of nosocomial infections in critically ill patients in a tertiary care Intensive Care Unit of Northern India. Saudi J Anaesth. 2017;11(4):402-407.
  4. Oliveira AC, Kovner CT, da Silva RS. Nosocomial infection in an intensive care unit in a Brazilian university hospital. Rev Lat Am Enfermagem. 2010;18(2):233-239.
  5. Karabey S. Hospital infections: definitions. Hastane İnfeksiyonları. Doğanay M, Ünal S (Ed). Ankara. Bilimsel Tıp Yayınevi, 2013. p.35-57.
  6. Ulusal Sağlık Hizmeti İlişkili Enfeksiyonlar Sürveyans Rehberi Ankara 2024 [Internet] Available from: https://dosyaism.saglik.gov.tr/Eklenti/15719,ulusal-saglik- hizmeti-iliskili-enf-surveyansi-rehberipdf.pdf?0. Accessed: 05.06.2024
  7. Arslan H, Gürdoğan K. Yoğun bakım ünitelerinde gözlenen hastane infeksiyonları. Hastane İnfeksiyonları Dergisi. 1999;3:165-170.
  8. Yılmaz G, Çevik MA, Erdinç FŞ, Tülek N. Nöroloji yoğun bakım ünitesinde gelişen nozokomiyal infeksiyon risk faktörlerinin değerlendirilmesi. Hastane İnfeksiyonları Dergisi. 2002;6(1):24-31.

Details

Primary Language

English

Subjects

Infectious Agents

Journal Section

Research Article

Early Pub Date

September 12, 2024

Publication Date

August 31, 2024

Submission Date

June 6, 2024

Acceptance Date

July 27, 2024

Published in Issue

Year 2024 Volume: 8 Number: 2

APA
Aydın, M., Aydın, N. N., Savaş, G., İba Yılmaz, S., & Alada, D. M. (2024). Evaluation of Healthcare-Associated Infections in Intensive Care Units. Journal of Biotechnology and Strategic Health Research, 8(2), 100-107. https://doi.org/10.34084/bshr.1496654
AMA
1.Aydın M, Aydın NN, Savaş G, İba Yılmaz S, Alada DM. Evaluation of Healthcare-Associated Infections in Intensive Care Units. J Biotechnol and Strategic Health Res. 2024;8(2):100-107. doi:10.34084/bshr.1496654
Chicago
Aydın, Murat, Nurten Nur Aydın, Gülseren Savaş, Sibel İba Yılmaz, and Dursun Murat Alada. 2024. “Evaluation of Healthcare-Associated Infections in Intensive Care Units”. Journal of Biotechnology and Strategic Health Research 8 (2): 100-107. https://doi.org/10.34084/bshr.1496654.
EndNote
Aydın M, Aydın NN, Savaş G, İba Yılmaz S, Alada DM (August 1, 2024) Evaluation of Healthcare-Associated Infections in Intensive Care Units. Journal of Biotechnology and Strategic Health Research 8 2 100–107.
IEEE
[1]M. Aydın, N. N. Aydın, G. Savaş, S. İba Yılmaz, and D. M. Alada, “Evaluation of Healthcare-Associated Infections in Intensive Care Units”, J Biotechnol and Strategic Health Res, vol. 8, no. 2, pp. 100–107, Aug. 2024, doi: 10.34084/bshr.1496654.
ISNAD
Aydın, Murat - Aydın, Nurten Nur - Savaş, Gülseren - İba Yılmaz, Sibel - Alada, Dursun Murat. “Evaluation of Healthcare-Associated Infections in Intensive Care Units”. Journal of Biotechnology and Strategic Health Research 8/2 (August 1, 2024): 100-107. https://doi.org/10.34084/bshr.1496654.
JAMA
1.Aydın M, Aydın NN, Savaş G, İba Yılmaz S, Alada DM. Evaluation of Healthcare-Associated Infections in Intensive Care Units. J Biotechnol and Strategic Health Res. 2024;8:100–107.
MLA
Aydın, Murat, et al. “Evaluation of Healthcare-Associated Infections in Intensive Care Units”. Journal of Biotechnology and Strategic Health Research, vol. 8, no. 2, Aug. 2024, pp. 100-7, doi:10.34084/bshr.1496654.
Vancouver
1.Murat Aydın, Nurten Nur Aydın, Gülseren Savaş, Sibel İba Yılmaz, Dursun Murat Alada. Evaluation of Healthcare-Associated Infections in Intensive Care Units. J Biotechnol and Strategic Health Res. 2024 Aug. 1;8(2):100-7. doi:10.34084/bshr.1496654

Journal of Biotechnology and Strategic Health Research